Skip To Main Content
Manjunath Nookala Krishnamurthy on Muck Rack

Manjunath Nookala Krishnamurthy

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Manjunath Nookala

Contact Manjunath Nookala, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia

|
By Gaurav Narula, Manjunath Nookala Krishnamurthy, Khushboo Gandhi, Ankita Awase
| ascopubs.org
Acute lymphoblastic leukemia (ALL) is a malignant conversion of rapidly growing lymphoid progenitor cells. 1,2 Patients with ALL in higher-income countries have better survival rates (> 80%) than do those in low- and middle-income countries (LMICs), for whom ALL survival rates are lower and range from 36% to 53%, which could be due to limitations in health care, differences in general health, and maybe the biology of ALL.
Open in Who Shared Issue with article?
See all 1 articles